The Geschwind Lab

  • Increase font size
  • Default font size
  • Decrease font size
The Geschwind Lab
The Geschwind laboratory is working to improve our understanding of human neuropsychiatric diseases, such as autism and neurodegenerative diseases, and their relationship to the range of normal human higher cognitive function. We use a combination of genetic, functional genomic and neurobiological methods in our work--frequently in collaboration with other laboratories or disciplines. Our methodological focus involves the application of network analyses and systems biology, which offer the promise of integration of multiple levels of data, connecting molecular pathways to nervous system function in health and disease.

image courtesy of Mitch Tobias, UCLA Medicine Magazine
Dr. Daniel Geschwind is the Gordon and Virginia MacDonald Distinguished Chair in Human Genetics and is a professor of neurology and psychiatry at the UCLA School of Medicine. He is director of the Neurogenetics Program and the Center for Autism Research and Treatment (CART) and co-director of the Center for Neurobehavioral Genetics at UCLA. Dr. Geschwind obtained an A.B. in psychology and chemistry at Dartmouth College and his M.D./Ph.D. at Yale School of Medicine prior to completing his internship, residency, and postdoctoral fellowship at UCLA. He joined the UCLA faculty in 1997. Link to biosketch
In addition to his research, Dr. Geschwind is active on the scientific advisory boards of The Faculty of 1000 Medicine, Autism Speaks, and the NIMH Scientific Advisory Council. He received the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association in 2004, the Scientific Service Award from Autism Speaks in 2008, and was inducted into the Institute of Medicine (IOM) of the National Academies in 2011.

 
  • CNTNAP2 mouse
    Absence of CNTNAP2 Leads to Epilepsy,Neuronal Migration Abnormalities,and Core Autism-Related Deficits.
    Although many ...
  • In vitro human cell model of GRN deficiency
    Ezra Y. Rosen
    Progranulin (GRN) mutations cause frontotemporal dementia (FTD), but GRN’s function in ...
  • Human-specific transcriptional regulation of CNS development genes by FOXP2

    Human-specific transcriptional regulation of CNS development genes by FOXP2

    Read more...
  • Neuroscience in the era of functional genomics and systems biology.

    Neuroscience in the era of functional genomics and systems biology

    ...

[Pause]

New Model for Autism Treatment

New Model for Autism Treatment

New pathway in FTD

New pathway in FTD